Search

To address unsafe practices and at-risk behaviors associated with the preparation and administration of I.V. push medications in adults, the Institute for Safe Medication Practices (ISMP) obtained an educational grant from BD to hold a national summit of expert stakeholders” Shastay (2016).

Extract:

“To address unsafe practices and at-risk behaviors associated with the preparation and administration of I.V. push medications in adults, the Institute for Safe Medication Practices (ISMP) obtained an educational grant from BD to hold a national summit of expert stakeholders. The 56 participants included representatives from hospitals and other frontline providers, professional organizations such as the Infusion Nurses Society (INS) and the ECRI Institute, regulatory bodies such as the FDA and The Joint Commission, and product vendors.

[ctt tweet=”ReTweet if useful… Guidelines on the preparation and administration of IV push medication http://ctt.ec/c7U_7+ @ivteam #ivteam” coverup=”c7U_7″]

During the 2-day summit, participants reached consensus on various practices for I.V. push medications, relying on the synthesis of the best evidence currently available, expert opinion, and manufacturers’ guidelines. Regulatory requirements were also acknowledged and included as appropriate. All summit participants were volunteers and received no compensation beyond travel and meeting expense reimbursement”.

[button link=”http://journals.lww.com/nursing/Fulltext/2016/10000/Evidence_based_safe_practice_guidelines_for_I_V_.12.aspx” color=”default”]Full Text[/button]

Reference:

Shastay, A.D. (2016) Evidence-based safe practice guidelines for I.V. push medications. Nursing. 46(10), p.38–44.

doi: 10.1097/01.NURSE.0000494641.31939.46

Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]